Skip to content

Genomic DNA in Human Blastocoele Fluid

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01780415
Enrollment
35
Registered
2013-01-31
Start date
2013-01-31
Completion date
2022-01-31
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chromosomal Aneuploidies, Single Gene Desease

Keywords

Blastocoele fluid, Human DNA, molecular diagnosis

Brief summary

The objective will focus on the characterization of DNA fragments present in Blastocoele fluid, and the evaluation of these fragments as potential target for Preimplantation Genetic Diagnosis. To reach this goal, real-time PCR, Whole Genome Amplification techniques and -subsequently- Next Generation Sequencing and aCGH approaches will be used.

Interventions

OTHERblastocoele aspiration

Sponsors

Cervesi Hospital, Cattolica, Italy
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* IVF patient with supernumerary embryos to vitrify at blastocyst stage

Exclusion criteria

* IVF patient without blastocyst formation

Design outcomes

Primary

MeasureTime frameDescription
Number of samples with DNA in blastocoele Fluid6 monththe presence of DNA will be evaluated through rtPCR

Secondary

MeasureTime frameDescription
Number of euploid samples8 monthsArray CGH

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026